Principal Financial Group Inc Neogenomics Inc Transaction History

Principal Financial Group Inc

  • $176 Billion
  • Q2 2025

A detailed history of Principal Financial Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 638,283 shares of NEO stock, worth $6.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
638,283
Previous 639,411 0.18%
Holding current value
$6.18 Million
Previous $6.07 Million 23.12%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
SELL
$6.4 - $10.27 $7,219 - $11,584
-1,128 Reduced 0.18%
638,283 $4.67 Million
Q1 2025

Apr 28, 2025
BUY
$9.09 - $18.61 $150,548 - $308,218
16,562 Added 2.66%
639,411 $6.07 Million
Q4 2024

Jan 31, 2025
BUY
$13.0 - $18.43 $8.1 Million - $11.5 Million
622,849 New
622,849 $10.3 Million
Q3 2024

Oct 31, 2024
SELL
$13.4 - $17.73 $348,400 - $460,980
-26,000 Reduced 4.12%
604,394 $8.91 Million
Q2 2024

Jul 29, 2024
SELL
$13.01 - $15.77 $411,961 - $499,357
-31,665 Reduced 4.78%
630,394 $8.74 Million
Q1 2024

Apr 29, 2024
SELL
$14.06 - $16.79 $31,522 - $37,643
-2,242 Reduced 0.34%
662,059 $10.4 Million
Q4 2023

Feb 07, 2024
SELL
$11.67 - $20.73 $268,013 - $476,085
-22,966 Reduced 3.34%
664,301 $10.7 Million
Q3 2023

Nov 02, 2023
SELL
$12.15 - $17.85 $459,112 - $674,497
-37,787 Reduced 5.21%
687,267 $8.45 Million
Q2 2023

Aug 07, 2023
SELL
$14.1 - $19.83 $806,336 - $1.13 Million
-57,187 Reduced 7.31%
725,054 $11.7 Million
Q1 2023

May 09, 2023
SELL
$9.09 - $19.45 $82,509 - $176,547
-9,077 Reduced 1.15%
782,241 $13.6 Million
Q4 2022

Feb 09, 2023
BUY
$6.45 - $12.07 $15,892 - $29,740
2,464 Added 0.31%
791,318 $7.31 Million
Q3 2022

Nov 09, 2022
BUY
$7.86 - $12.91 $43,733 - $71,831
5,564 Added 0.71%
788,854 $6.79 Million
Q2 2022

Aug 10, 2022
SELL
$7.06 - $13.97 $450,145 - $890,727
-63,760 Reduced 7.53%
783,290 $6.38 Million
Q1 2022

May 09, 2022
SELL
$12.15 - $35.28 $75,475 - $219,159
-6,212 Reduced 0.73%
847,050 $10.3 Million
Q4 2021

Feb 09, 2022
SELL
$30.49 - $48.49 $231,998 - $368,960
-7,609 Reduced 0.88%
853,262 $29.1 Million
Q3 2021

Nov 09, 2021
BUY
$41.66 - $52.52 $1.14 Million - $1.43 Million
27,306 Added 3.28%
860,871 $41.5 Million
Q2 2021

Aug 10, 2021
SELL
$36.62 - $51.69 $666,300 - $940,499
-18,195 Reduced 2.14%
833,565 $37.7 Million
Q1 2021

May 10, 2021
BUY
$41.56 - $59.88 $1.59 Million - $2.29 Million
38,309 Added 4.71%
851,760 $41.1 Million
Q4 2020

Feb 08, 2021
BUY
$36.08 - $56.47 $267,497 - $418,668
7,414 Added 0.92%
813,451 $43.8 Million
Q3 2020

Nov 06, 2020
SELL
$33.26 - $40.48 $1.04 Million - $1.26 Million
-31,132 Reduced 3.72%
806,037 $29.7 Million
Q2 2020

Aug 05, 2020
BUY
$24.21 - $31.02 $867,783 - $1.11 Million
35,844 Added 4.47%
837,169 $25.9 Million
Q1 2020

May 12, 2020
SELL
$20.5 - $34.53 $675,167 - $1.14 Million
-32,935 Reduced 3.95%
801,325 $22.1 Million
Q4 2019

Feb 05, 2020
SELL
$18.96 - $29.84 $1.02 Million - $1.6 Million
-53,652 Reduced 6.04%
834,260 $24.4 Million
Q3 2019

Nov 13, 2019
BUY
$19.12 - $26.24 $110,857 - $152,139
5,798 Added 0.66%
887,912 $17 Million
Q2 2019

Aug 12, 2019
BUY
$19.57 - $24.1 $1.34 Million - $1.64 Million
68,243 Added 8.38%
882,114 $19.4 Million
Q1 2019

May 10, 2019
BUY
$12.14 - $20.46 $9.24 Million - $15.6 Million
761,137 Added 1443.35%
813,871 $16.7 Million
Q4 2018

Feb 14, 2019
BUY
$11.24 - $18.5 $460,120 - $757,316
40,936 Added 346.97%
52,734 $665,000
Q3 2018

Nov 14, 2018
BUY
$12.5 - $15.38 $147,475 - $181,453
11,798 New
11,798 $181,000

Others Institutions Holding NEO

# of Institutions
307
Shares Held
127M
Call Options Held
1.17M
Put Options Held
297K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.22B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email